ChemPath: Potassium Flashcards

1
Q

What is the normal range for serum potassium?

A

3.5-5.0 mmol/L

(most abundant intracellular cation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

where is potassium more abundant

A

intracellularly (most abundant intracellular cation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the two main hormones involved in the regulation of potassium?

A
  • Angiotensin II
  • Aldosterone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Outline how the renin-angiotensin-aldosterone system works.

A
  • Reduced perfusion/low BP in renal artery or low sodium will stimulate the production of renin from the juxta-glomerular cells
  • This cleaves angiotensinogen (from liver) to angiotensin I
  • This is then converted by ACE in the lungs to angiotensin II → stimulates aldosterone release from the adrenals
  • Aldosterone stimulates sodium reabsorption and potassium excretion in the principal cells of the cortical collecting tubule

NOTE: water will also be drawn in with the sodium so aldosterone should not greatly affect sodium concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Outline the mechanisms of action of aldosterone.

A
  • Aldosterone binds to MR steroid receptor and stimulates the transcription of ENaC channels (epithelial sodium channels)
  • As you reabsorb more sodium, the lumen becomes more negative and K+ will move down the electrochemical gradient into the lumen via ROMK channels and therefore is excreted.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the main stimuli for aldosterone release?

A
  • Angiotensin II
  • High potassium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List causes of hyperkalaemia.

A
  • Renal impairment = reduced GFR
  • Drugs
    • ACE inhibitors = decreased angiotensin II → decreased Aldosterone
    • ARB = inhibit Angiotensin II binding in Adrenal → decreased Aldost.
    • Aldosterone antagonist (Spironolactone) → decreased K+ excretion
  • Addison’s disease (low aldosterone release)
  • Potassium release from cells (rhabdomyolysis, acidosis, tumour lysis syndrome)
  • Reduced renin activity (renal tubular acidosis type 4, NSAIDs)

in bold = main causes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain how acidosis leads to hyperkalaemia.

A
  • When plasma H+ concentration is high, the cells try to take in more H+ from the plasma
  • To maintain electrochemical neutrality, K+ must leave the cell when H+ enters
  • This leads to hyperkalaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

In a patient with hyperkalaemia - what non-invasive test must you always do

A

ECG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ECG changes associated with hyperkalaemia

A
  • Peaked T wave (early)
  • Broad QRS
  • Flat P wave
  • Prolonged PR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Outline the effect of hyperkalaemia on muscle contraction

A

Increased levels of extracellular K+ ions increase the resting membrane potential (more positive as extracellular environment is less negative therefore less different to the intracellular negative env) to become more positive. This increases muscle excitability as resting membrane potential is closer to activation threshold potential.

As there is further increase in potassium, the threshold potential also shifts to become more positive to parralel the also positive shift of resting membrane potential. However, a more positive membrane potential is associated with a lower Vmax (maximum contractive response) when muscle is depolarised as it triggers less Na+ voltage gated channels to open.

TLDR Therefore in summary, the early effect of mild hyperkalemia on myocyte function is to increase myocyte excitability by shifting the resting membrane potential to a less negative value and thus closer to threshold potential; but as potassium levels continue to rise, myocyte depression occurs and Vmax continues to decrease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Outline the management of hyperkalaemia.

A
  • 10 ml 10% calcium gluconate (cardioprotective does nothing to reduce K+)
  • 50 ml 50% dextrose (prevent hypoglycaemia) + 10 U insulin (drive K+ into cells)
  • Nebulised salbutamol
  • Treat the cause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List some causes of hypokalaemia.
(GRRR)

A

Either depletion or intracellular shift.

  • GI loss (diarrhoea)
  • Renal loss
    • Hyperaldosteronism, iatrogenic excess cortisol
    • Increased sodium delivery to distal nephron
    • Osmotic diuresis
  • Redistribution into cells
    • Insulins
    • Beta-agonists
    • Alkalosis (shift of K+ into cells in exchange for H+ to balance pH change)
  • Rare causes
    • Renal tubular acidosis (type 1 and 2)
    • Hypomagnesaemia (low Mg means you can’t correct low K+ - first must correct low Mg)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name a condition and a drug that can block the triple transporter (Na+ K+ Cl-).

A

Triple transporter is located in thick ascending loop (TAL) of henlee. Reabsorbs Na+, 2Cl-, K+ molecules.

  • Loop diuretics (frusomide)
  • Bartter syndrome (mutation in triple transporter)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name one medication and one disorder that can block the Na+/Cl- cotransporter.

A
  • Thiazide diuretics
  • Gitelman syndrome (mutation in Na+/Cl- cotransporter)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain how increased delivery of sodium to the distal nephron can cause hypokalaemia.

A
  • Increased delivery of Na+ to the distal nephron (e.g. because of blocking/ineffective triple transporter or Na+/Cl- cotransporter) leads to increased reabsorption of Na+ in the distal nephron
  • This leads to the lumen of the distal nephron becoming more negative
  • This results in the movement of K+ down the electrochemical gradient through ROMK channels into the lumen
17
Q

What are the clinical features of hypokalaemia?

A
  • Muscle weakness
  • Arrythmia
  • Polyuria and polydipsia (hypokalaemia leads to nephrogenic DI)
18
Q

What screening test should be done in a patient with hypokalaemia and hypertension?

A

Aldosterone: renin ratio (primary hyperaldosteronism (e.g. Conn’s Syndrome) will show high aldosterone and low renin)

19
Q

Outline the management of hypokalaemia:

  1. 3-3.5 mmol/L
  2. <3 mmol/L
A
  1. 3-3.5 mmol/L
    • Oral potassium chloride (2x SandoK TDS for 48 hours)
    • Re-check serum K+ concentration
  2. < 3 mmol/L
    • IV potassium chloride infusion
    • Maximum rate: 10 mmol/hr
    • NOTE: rates > 20 mmol/hr irritate the superficial veins
    • TREAT THE CAUSE